Standout Papers

First-in-Human Phase I/IB Dose-Finding Study of Adagrasib (MRTX849) in Patients With Advanced <i>KRAS</i><sup><i>G12C</i>... 2022 2026 2023 2024186
  1. First-in-Human Phase I/IB Dose-Finding Study of Adagrasib (MRTX849) in Patients With Advanced KRASG12C Solid Tumors (KRYSTAL-1) (2022)
    Sai‐Hong Ignatius Ou, Pasi A. Jänne et al. Journal of Clinical Oncology

Immediate Impact

1 by Nobel laureates 61 standout
Sub-graph 1 of 24

Citing Papers

New clinical trial design in precision medicine: discovery, development and direction
2024 Standout
Colorimetric sensing for translational applications: from colorants to mechanisms
2024 Standout
1 intermediate paper

Works of Cornelius Cilliers being referenced

First-in-Human Phase I/IB Dose-Finding Study of Adagrasib (MRTX849) in Patients With Advanced KRASG12C Solid Tumors (KRYSTAL-1)
2022 Standout
Improved Tumor Penetration and Single-Cell Targeting of Antibody–Drug Conjugates Increases Anticancer Efficacy and Host Survival
2017

Author Peers

Author Last Decade Papers Cites
Cornelius Cilliers 449 334 282 17 719
Alexander H. Staudacher 417 339 215 31 736
Nadège Gaborit 445 261 364 24 759
Sébastien Gouard 252 438 159 36 734
Erasmus Poku 291 400 151 31 627
Dan Sandberg 353 564 153 12 671
Leslie Wetzel 448 289 184 11 639
Matthew Sung 416 263 277 17 800
Hadis Honarvar 398 684 306 30 844
R Boden 198 526 350 28 794
Gregory Z. Ferl 207 447 250 30 702

All Works

Loading papers...

Rankless by CCL
2026